+1-518-618-1030 866 - 552 - 3453 USA-Canada Toll Free

Global Non-Invasive Prenatal Testing Market: Rising Average Maternal Age Worldwide to Fuel Market at 17.50% CAGR

Posted on Oct 27, 2015

According to a recent market research report released by Transparency Market Research, the global non-invasive prenatal testing market is projected to expand at a CAGR of 17.5% during the period between 2014 and 2022. The report, titled “Non-invasive Prenatal Testing Market - Global Industry Analysis, Size, Volume, Share, Growth, Trends and Forecast 2014 - 2022”, estimates the global non-invasive prenatal testing market to reach a valuation of US$2.38 bn by 2022. The overall market was worth US$0.53 bn in 2013.


Browse the full Non-invasive Prenatal Testing (NIPT) Market (BambniTest, Harmony, informaSeq, MaterniT21 PLUS, NIFTY, Panorama, PrenaTest, verifi, VisibiliT and Others) - Global Industry Analysis, Size, Volume, Share, Growth, Trends and Forecast 2014 - 2022 report at http://www.transparencymarketresearch.com/noninvasive-prenatal-diagnostics-market.html


Non-invasive prenatal testing is done for screening pregnant women who are at high risk of delivering babies with fetal chromosomal disorders such as Edwards syndrome, Down syndrome, Turner syndrome, Patau syndrome, and others. The report cites that the rising average maternal age worldwide has led to high incidence of babies born with chromosomal disorders. Increasing demand for non-invasive and early fetal testing procedures has contributed towards the growth of the global non-invasive prenatal testing market. However, the report states that regulatory guidelines and ethical hurdles will restrict the growth of the overall market during the forecast horizon. Further, the limitations of non-invasive prenatal tests and the availability of other screening and testing methods will pose challenges in front of the market. The global non-invasive prenatal testing market has a huge opportunity to grow in the emerging market of Asia. 


On the basis of tests, the report segments the global non-invasive prenatal testing market into Harmony, Babmni test, NIFTY, MaterniT21 PLUS, informaSeq, PrenaTest, Panorama, VisibiliT, verifi, amd others. These tests are based on the direct analysis of cell-free fetal DNA in mother’s blood. MaterniT21 PLUS was the first non-invasive prenatal test introduced in the market in 2011 for the diagnosis of trisomy 21. In 2013, MaterniT21 PLUS was the most accepted test in the market and led the overall market with 36.1% of the market revenue. However, the report points out that during the forecast period, the number of MaterniT21 tests performed will decrease with the commercialization of other tests such as Panorama, NIFTY, and verifi. The recent CFDA approval for Bambni test will increase its demand in the coming years.

The report segments the global non-invasive prenatal testing market across four key regions: Asia Pacific, North America, Europe, and Rest of the World. The market is expected to be driven by the demand from untapped regions such as Europe and Asia Pacific during the period between 2014 and 2022.


The report profiles some of the key players in the global non-invasive prenatal testing market such as Illumina, Inc. (Verinata Health, Inc.), Sequenom Inc., Ariosa Diagnostics, BGI Diagnostics, Natera Inc., LabCorp, LifeCodexx AG, and Berry Genomics. Several companies are investing in the development of new non-invasive prenatal tests. For example, Quest Diagnostics has developed a new non-invasive test by implementing the patented technology of Sequenom Inc. The test is likely to be commercialized by 2015. 


The research study has been segmented as below:


Global Non-Invasive Prenatal Testing Market, by Test

  • Bambni Test
  • Harmony
  • informaSeq
  • MaterniT21 PLUS
  • Panorama
  • PrenaTest
  • verifi
  • VisibiliT

Global Non-Invasive Prenatal Testing Market, by Geography

  • North America
  • Europe
  • Asia Pacific
  • Rest of the World

Browse : Our new press releases http://www.transparencymarketresearch.com/pressrelease/global-noninvasive-prenatal-diagnostics-market.htm



About Us

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information. 


TMR’s data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With extensive research and analysis capabilities, Transparency Market Research employs rigorous primary and secondary research techniques to develop distinctive data sets and research material for business reports.



Mr. Sudip S 

90 State Street, Suite 700

Albany, NY 12207

Tel: +1-518-618-1030

USA - Canada Toll Free: 866-552-3453

Email: sales@transparencymarketresearch.com

Website: http://www.transparencymarketresearch.com